Abstract
Objectives Neonatal and pediatric intestinal failure related to enterostomy is an infrequent but burdensome condition associated with substantial morbidity and mortality. This study presents the development and clinical validation of a novel device to resolve these problems, by formalizing a safe and efficient enterostomy chyme reinfusion technique.
Methods A novel neonatal chyme reinfusion device was designed and manufactured (‘The Insides Neo’, The Insides Company, New Zealand), prior to validation in a feasibility study in tertiary neonatal intensive care centres. Neonates with double enterostomy were recruited and commenced on chyme reinfusion therapy using the novel device to test safety, efficacy, tolerability, and usability within nursing workflows. Device and clinical outcomes were recorded along with nursing feedback. Registered under the ANZCTR, identifier no. ACTRN12621000835842p.
Results Ten neonates were recruited across two centres, with a median usage duration of 37.5 (range 12-84) days. Following initiation of therapy, rate of weight gain increased from mean 68.8 ± 37.4 to 197 ± 25.0 g/week (p=0.024). Of the 7/10 neonates on PN at commencement of therapy, 4/7 were able to wean and achieve enteral autonomy. All neonates tolerated the device with uniformly positive nursing feedback and minimal time to learn and incorporate the novel device into nursing workflows. There were no device-related adverse events.
Conclusions A novel device was developed and validated to be safe and effective at performing chyme reinfusion therapy in neonates. This device is anticipated to improve the clinical care and outcomes of neonatal patients with double enterostomies.
What is Known
Chyme reinfusion is widely accepted and is a standard of care in many centres who care for neonates with double enterostomy’s.
The manual application of chyme reinfusion has led to low adoption despite the many benefits.
What is New
A new device that automates the process of chyme reinfusion that overcomes many of the barriers outlined in the literature.
Uniformly positive nursing feedback that streamlines the Neonatal Intensive Care Unit (NICU) workflow.
Competing Interest Statement
E. Ludlow is an employee and shareholder in The Insides Company T. Harrington contracts to The Insides Company R. Davidson, J. Davidson, G. OGrady, and I. Bissett are Founders of The Insides Company
Clinical Trial
ACTRN12621000835842p
Funding Statement
The study was funded by a grant from Cure Kids to hire a research nurse and assist with research and development costs associated with The Insides Neo. Devices were supplied by The Insides Company.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
New Zealand Health and Disability Committees The Northern B Health and Disability Ethics Committee approved the study 16/Aug/2021 Ethics ref: 21/NTB/150 Study title: Neonate stoma refeeding device feasibility study
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This version of the manuscript has been revised and the Discussion and Methods have been updated with more clarification
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- NEC
- Necrotising enterocolitis
- CRT
- Chyme Reinfusion Therapy
- PN
- Parenteral Nutrition
- EN
- Enteral Nutrition
- NICU
- Neonatal Intensive Care Unit
